Page last updated: 2024-09-03

ah 6809 and 8-epi-prostaglandin f2alpha

ah 6809 has been researched along with 8-epi-prostaglandin f2alpha in 2 studies

Compound Research Comparison

Studies (ah 6809)	Trials (ah 6809)	Recent Studies (post-2010) (ah 6809)	Studies (8-epi-prostaglandin f2alpha)	Trials (8-epi-prostaglandin f2alpha)	Recent Studies (post-2010) (8-epi-prostaglandin f2alpha)
163	1	49	1,863	248	723

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, PJ; Belvisi, MG; Kawikova, I; Tadjkarimi, S; Takahashi, T; Yacoub, MH	1
Bessard, G; Chavanon, O; Cracowski, JL; Devillier, P; Hunt, M; Souvignet, C; Stanke-Labesque, F	1

Other Studies

2 other study(ies) available for ah 6809 and 8-epi-prostaglandin f2alpha

Article	Year
8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Animals; Bronchoconstriction; Dinoprost; Dioxanes; Dose-Response Relationship, Drug; F2-Isoprostanes; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Thromboxane A2; Trachea; Xanthenes; Xanthones	1996
Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)]. European journal of pharmacology, 2000, May-26, Volume: 397, Issue:1 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Benzoquinones; Biphenyl Compounds; Dinoprost; Dose-Response Relationship, Drug; F2-Isoprostanes; Female; Flavanones; Flavonoids; Heptanoic Acids; Humans; In Vitro Techniques; Leukotrienes; Lipoxygenase Inhibitors; Male; Mammary Arteries; Middle Aged; Prostaglandin Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Thromboxane B2; Vasoconstriction; Vasoconstrictor Agents; Xanthenes; Xanthones	2000

Article

Year

8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.

American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:2

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Animals; Bronchoconstriction; Dinoprost; Dioxanes; Dose-Response Relationship, Drug; F2-Isoprostanes; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Thromboxane A2; Trachea; Xanthenes; Xanthones

1996

Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].

European journal of pharmacology, 2000, May-26, Volume: 397, Issue:1

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Benzoquinones; Biphenyl Compounds; Dinoprost; Dose-Response Relationship, Drug; F2-Isoprostanes; Female; Flavanones; Flavonoids; Heptanoic Acids; Humans; In Vitro Techniques; Leukotrienes; Lipoxygenase Inhibitors; Male; Mammary Arteries; Middle Aged; Prostaglandin Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Thromboxane B2; Vasoconstriction; Vasoconstrictor Agents; Xanthenes; Xanthones

2000